A Retrospective Real-World Comparison of Topical Delgocitinib and Localized Cream Psoralen–Ultraviolet A in Chronic Hand Eczema

Abstract Introduction Chronic hand eczema (CHE) remains difficult to treat, particularly in patients unresponsive or intolerant to topical corticosteroids. Although topical delgocitinib, the first topical JAK inhibitor approved for CHE, provides a steroid-free alternative, comparative real-world dat...

Полное описание

Библиографические подробности

Главные авторы:	Stefan Weißinger, Eva Oppel, Nils Kurzen, Carolin Ertl, Dirk Tomsitz, Teodora Pumnea, Surina Frey, Felix Lauffer
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Adis, Springer Healthcare 2026-03-01
Серии:	Dermatology and Therapy
Предметы:	Chronic hand eczema Delgocitinib PUVA Real-world study DLQI Maintenance
Online-ссылка:	https://doi.org/10.1007/s13555-026-01705-1
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!